Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Front Cell Infect Microbiol ; 14: 1339285, 2024.
Article in English | MEDLINE | ID: mdl-38720961

ABSTRACT

Antimicrobial peptides (AMPs), often referred to as nature's antibiotics, are ubiquitous in living organisms, spanning from bacteria to humans. Their potency, versatility, and unique mechanisms of action have garnered significant research attention. Unlike conventional antibiotics, peptides are biodegradable, adding to their appeal as potential candidates to address bacterial resistance in livestock farming-a challenge that has been under scrutiny for decades. This issue is complex and multifactorial, influenced by a variety of components. The World Health Organization (WHO) has proposed a comprehensive approach known as One Health, emphasizing the interconnectedness of human-animal-environment relationships in tackling such challenges. This review explores the application of AMPs in livestock farming and how they can mitigate the impact of this practice within the One Health framework.


Subject(s)
Antimicrobial Peptides , Livestock , One Health , Livestock/microbiology , Animals , Humans , Antimicrobial Peptides/pharmacology , Drug Resistance, Bacterial , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects
2.
Scand J Gastroenterol ; 58(12): 1547-1554, 2023.
Article in English | MEDLINE | ID: mdl-37489111

ABSTRACT

INTRODUCTION: Percutaneous left atrial appendage closure (LAAC) has shown non-inferiority compared to oral anticoagulation (OAC) in preventing atrial fibrillation (AF)-related stroke. The objective of this study was to assess whether LAAC reduces the incidence of gastrointestinal bleeding (GIB) and/or chronic anaemia associated with OAC, as well as the consumption of healthcare resources. MATERIALS AND METHODS: Prospective, single-center study from 2016 to 2022, LAAC was performed. Clinical, analytical and healthcare resource consumption data were collected (endoscopies, blood transfusions, hospital admissions) prior and 6 months after LAAC. RESULTS: 43 patients were included, with an average age of 77.6 years. LAAC indication was upper, low and obscure GIB in 7 (16%), 8 (19%) and 28 patients (65%) respectively. GIB source was intestinal angiodysplasias in 27 patients (63%), occult origin in 12 (28%), and others (antral vascular ectasia, portal hypertension gastropathy, etc.) in 4 patients (9%). The mean number of packed red blood cells per patient before LAAC was (mean ± SD) 7.29 ± 5 vs 0.42 ± 1.3 (p < 0.001); endoscopic procedures were 4.34 ± 2.85 vs 0.27 ± 0.76 (p < 0.001); and hospitalizations 2.67 ± 2.14 vs 0.03 ± 0.17 (p < 0.001), with a hospital stay of 21.5 ± 17.3 vs 0.09 ± 0.5 days (p < 0.001) at 6 months post-intervention. Haemoglobin value increased from 8.1 ± 1.2g/dl to 12.4 ± 2.2g/dl (p < 0.001) at 6 months. No thromboembolic events were registered during a median follow-up of 16.6 months (range 6-65). CONCLUSIONS: LAAC could be a safe and effective alternative to OAC in patients with non-valvular AF presenting significant, recurrent or potentially unresolvable GIB. This intervention also leads to important savings in the consumption of healthcare resources.


Subject(s)
Atrial Appendage , Atrial Fibrillation , Stroke , Humans , Aged , Atrial Appendage/surgery , Prospective Studies , Anticoagulants/adverse effects , Stroke/prevention & control , Stroke/complications , Atrial Fibrillation/complications , Gastrointestinal Hemorrhage/complications , Treatment Outcome
3.
J Invasive Cardiol ; 34(8): E642, 2022 08.
Article in English | MEDLINE | ID: mdl-35920735

ABSTRACT

A 78-year-old woman with a history of hypertension, hyperlipidemia, and asthma was referred to her cardiologist for chest pain and dyspnea on exertion. After performing stress echocardiography, it was determined that closure of the fistula with coils was indicated. This case highlights that coronary fistula could be an unusual entity of angina, clinically improving after the occlusion procedure.


Subject(s)
Arterio-Arterial Fistula , Coronary Artery Disease , Coronary Vessel Anomalies , Fistula , Aged , Angina Pectoris/diagnosis , Angina Pectoris/etiology , Animals , Arterio-Arterial Fistula/complications , Arterio-Arterial Fistula/diagnosis , Arterio-Arterial Fistula/surgery , Coronary Angiography , Elapidae , Female , Humans , Pulmonary Artery/diagnostic imaging
5.
Rev Med Inst Mex Seguro Soc ; 49(3): 259-66, 2011.
Article in English | MEDLINE | ID: mdl-21850798

ABSTRACT

OBJECTIVE: to demonstrate whether patients undergoing capsulotomy Nd: YAG laser developed intraocular hypertension after the procedure. METHODS: prospective, pre-experimental before and after 2 measurements with post-test in patients with posterior capsular opacity from the Ophthalmology Service. Measurements of intraocular pressure (IP) before capsulotomy Nd: YAG laser, and three hours and one week later. RESULTS: we studied 47 patients, 29.8 % were men and 70.2 % women. We compared between visual acuity before and one week later (Wilcoxon test p = 0.00). IP after three hours and one week later, comparisons with Friedman test were done (p =0. 002). We compared the IP prior and one week later (Wilcoxon test, with p =0.815). IP before and three hours later were obtained (p = 0.001) and IP three hours and one week later ( p = 0.004). CONCLUSIONS: we found an increase in IP in the first hours after the capsulotomy Nd: YAG laser, which decrease gradually until reaching the values presented before the procedure, in not more than a week period. It is a quick and safe procedure to treat posterior capsular opacity.


Subject(s)
Intraocular Pressure , Lasers, Solid-State/adverse effects , Lens Capsule, Crystalline/surgery , Ocular Hypertension/etiology , Ocular Hypertension/physiopathology , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prospective Studies
6.
Int J Cardiol ; 127(3): e183-5, 2008 Jul 21.
Article in English | MEDLINE | ID: mdl-17669520

ABSTRACT

Acute myocardial infarction (AMI) is infrequent in patients with idiopathic thrombocytopenic purpura (ITP) so the best treatment is not well known. The next case shows a 37-year-old man with chronic ITP who suffered an anterior AMI, the platelet count at admission was 39,000 microL. He was treated successfully with primary percutaneous angioplasty under anticoagulation with unfractionated heparin and antiaggregation with clopidogrel and ASA. At the end of the procedure we sealed the femoral access site with Angio-Seal(R). He didn t have any complications during the procedure and after six months remained asymptomatic. In some patients with chronic ITP and AMI the percutaneous treatment could be a good option.


Subject(s)
Angioplasty, Balloon, Coronary , Myocardial Infarction/therapy , Purpura, Thrombocytopenic, Idiopathic/therapy , Adult , Angioplasty, Balloon, Coronary/methods , Humans , Male , Myocardial Infarction/diagnosis , Purpura, Thrombocytopenic, Idiopathic/diagnosis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...